MedTrace Logo

The Effect of an Enhanced Rice Bran Nutritional Supplement in HIV

NCT02214173 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 47

Last updated 2016-07-18

No results posted yet for this study

Summary

The purpose of this study is to investigate the effects of the nutritional supplement rice bran arabinoxylan compound (RBAC) on metabolic syndrome variables in persons living with HIV. The hypothesis is that there will be a significant improvement in metabolic syndrome and immune variables in HIV-positive participants in the intervention group compared to the control group.

Conditions

  • Human Immunodeficiency Virus Infection

Interventions

DIETARY_SUPPLEMENT

rice bran arabinoxylan compound (RBAC)

2 capsules with 6 to 8 ounces of water 3 times per day (6 tablets total per day) for 6 months.

DIETARY_SUPPLEMENT

Placebo

2 capsules with 6 to 8 ounces of water 3 times per day (6 tablets total per day) for 6 months.

Sponsors & Collaborators

  • Daiwa Health Development

    collaborator OTHER

  • University of Miami

    lead OTHER

Principal Investigators

  • John E Lewis, Ph.D. · University of Miami

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02214173 on ClinicalTrials.gov